Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05139238
PHASE4

Postpartum Hypertension Study

Sponsor: Columbia University

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess which blood pressure medication (intravenous labetalol or oral nifedipine) works better in treating severely elevated blood pressure in women who have just delivered a baby.

Official title: Oral Nifedipine Versus Intravenous Labetalol for Postpartum (PP) Hypertensive Emergency: A Randomized Clinical Trial (RCT)

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

104

Start Date

2022-07-04

Completion Date

2027-12

Last Updated

2025-04-01

Healthy Volunteers

No

Interventions

DRUG

Labetalol

Intravenous labetalol, a short acting ant-hypertensive

DRUG

Nifedipine

Oral nifedipine, a short acting ant-hypertensive

Locations (1)

Columbia University Irving Medical Center

New York, New York, United States